HCA Insider Trading
HCA Healthcare, Inc. | Services-General Medical & Surgical Hospitals, NEC
Comprehensive Trading Performance Summary
The investment history of corporate insiders at HCA Healthcare, Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Services-General Medical & Surgical Hospitals, NEC sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 03:18 | 2026-02-18 | McAlevey Michael R | Officer - EVP & Chief Legal & Admin Off. | OPT+S | $533.37 | 1,694 | $903,537 | 8,853 | 0.0% |
| 2026-02-13 02:55 | 2026-02-11 | Wyatt Christopher F. | Officer - SVP & Controller | SELL | $505.00 | 4,000 | $2,020,000 | 44,379 | -8.3% |
| 2026-02-13 02:36 | 2026-02-11 | Berres Jennifer | Officer - SVP & Chief Human Res. Officer | SELL | $514.58 | 8,020 | $4,126,950 | 11,993 | -40.1% |
| 2026-02-06 02:33 | 2026-02-03 | HAZEN SAMUEL N | Director, Officer - CEO | SELL | $501.04 | 42,877 | $21,483,276 | 32,276 | -57.1% |
| 2026-02-06 02:22 | 2026-02-03 | Cuffe Michael S. | Officer - EVP and Chief Clinical Officer | SELL | $498.09 | 1,500 | $747,135 | 30,003 | -4.8% |
| 2025-11-06 02:15 | 2025-11-05 | McAlevey Michael R | Officer - EVP & Chief Legal & Admin Off. | OPT+S | $473.79 | 3,892 | $1,843,991 | 3,487 | 0.0% |
| 2025-09-09 01:37 | 2025-09-08 | Cuffe Michael S. | Officer - EVP and Chief Clinical Officer | OPT+S | $418.84 | 3,836 | $1,606,670 | 31,503 | 0.0% |
| 2025-05-16 00:54 | 2025-05-13 | Foster Jon M | Officer - EVP and COO | SELL | $369.32 | 15,698 | $5,797,661 | 12,646 | -55.4% |
| 2025-03-28 23:11 | 2011-07-26 | BANK OF AMERICA CORP /DE/ | 10% owner | BUY | $25.67 | 3,436 | $88,208 | 0 | +100.0% |
| 2025-03-28 23:11 | 2012-01-10 | BANK OF AMERICA CORP /DE/ | 10% owner | SELL | $25.12 | 3,178 | $79,816 | 0 | -100.0% |
| 2025-02-19 03:28 | 2025-02-14 | Berres Jennifer | Officer - SVP & Chief Human Res. Officer | SELL | $322.59 | 9,533 | $3,075,240 | 15,412 | -38.2% |
| 2024-11-19 01:50 | 2024-11-14 | Whalen Kathleen M | Officer - SVP & Chief Ethics Officer | SELL | $357.99 | 1,474 | $527,677 | 9,454 | -13.5% |
| 2024-11-15 02:53 | 2024-11-14 | Billington Phillip G | Officer - SVP-Internal Audit Services | OPT+S | $350.00 | 3,897 | $1,363,950 | 52,702 | 0.0% |
| 2024-11-15 02:50 | 2024-11-14 | Akdamar Erol R | Officer - Group President | OPT+S | $353.00 | 2,900 | $1,023,700 | 6,843 | 0.0% |
| 2024-09-13 00:21 | 2024-09-12 | Cuffe Michael S. | Officer - EVP and Chief Clinical Officer | OPT+S | $385.42 | 8,358 | $3,221,340 | 29,678 | 0.0% |
| 2024-08-01 00:44 | 2024-07-29 | Whalen Kathleen M | Officer - SVP & Chief Ethics Officer | OPT+S | $362.13 | 4,851 | $1,756,695 | 9,454 | 0.0% |
| 2024-08-01 00:12 | 2024-07-29 | Reiner Deborah M | Officer - SVP - Mktg. & Communications | SELL | $359.96 | 3,314 | $1,192,914 | 3,510 | -48.6% |
| 2024-07-30 00:25 | 2024-07-29 | Wyatt Christopher F. | Officer - SVP & Controller | OPT+S | $360.20 | 4,000 | $1,440,782 | 40,449 | 0.0% |
| 2024-07-30 00:18 | 2024-07-25 | Torres Kathryn A. | Officer - SVP-Payer Contracting & Align. | SELL | $355.05 | 1,857 | $659,328 | 17,755 | -9.5% |
| 2024-05-21 00:23 | 2024-05-16 | Whalen Kathleen M | Officer - SVP & Chief Ethics Officer | OPT+S | $326.30 | 3,204 | $1,045,465 | 9,454 | 0.0% |
| 2024-05-18 00:14 | 2024-05-15 | Torres Kathryn A. | Officer - SVP-Payer Contracting & Align. | SELL | $326.18 | 1,863 | $607,673 | 19,612 | -8.7% |
| 2024-05-14 00:08 | 2024-05-09 | Cuffe Michael S. | Officer - EVP and Chief Clinical Officer | SELL | $316.88 | 6,311 | $1,999,825 | 29,624 | -17.6% |
| 2024-05-14 00:07 | 2024-05-09 | Cohen Jeffrey E. | Officer - SVP-Government Relations | SELL | $313.00 | 1,650 | $516,450 | 5,185 | -24.1% |
| 2024-05-09 00:43 | 2024-05-06 | Cuffe Michael S. | Officer - EVP and Chief Clinical Officer | OPT+S | $309.00 | 1,600 | $494,400 | 34,124 | 0.0% |
| 2024-05-07 01:39 | 2024-05-02 | Torres Kathryn A. | Officer - SVP-Payer Contracting & Align. | SELL | $312.00 | 1,863 | $581,256 | 21,475 | -8.0% |
| 2024-03-21 00:16 | 2024-03-18 | Wasserman Chad J | Officer - SVP and CIO | OPT+S | $327.92 | 1,220 | $400,057 | 1,576 | 0.0% |
| 2024-02-14 03:03 | 2024-02-09 | Whalen Kathleen M | Officer - SVP & Chief Ethics Officer | SELL | $306.21 | 4,262 | $1,305,074 | 10,250 | -29.4% |
| 2024-02-08 03:45 | 2024-02-05 | Wyatt Christopher F. | Officer - SVP & Controller | SELL | $312.42 | 4,000 | $1,249,680 | 37,383 | -9.7% |
| 2024-02-07 02:34 | 2024-02-06 | RUTHERFORD BILL B | Officer - CFO and EVP | OPT+S | $310.63 | 6,000 | $1,863,780 | 8,448 | 0.0% |
| 2024-02-07 02:29 | 2024-02-05 | Mosier Sammie S | Officer - SVP & Chief Nurse Executive | OPT+S | $312.00 | 1,645 | $513,240 | 7,646 | 0.0% |
| 2024-02-07 02:28 | 2024-02-02 | Wasserman Chad J | Officer - SVP and CIO | OPT+S | $312.04 | 652 | $203,451 | 290 | 0.0% |
| 2024-02-03 02:51 | 2024-01-31 | Torres Kathryn A. | Officer - SVP-Payer Contracting & Align. | OPT+S | $307.00 | 3,861 | $1,185,327 | 15,899 | 0.0% |
| 2024-02-03 02:38 | 2024-01-31 | Cuffe Michael S. | Officer - EVP and Chief Clinical Officer | SELL | $306.79 | 3,200 | $981,734 | 24,929 | -11.4% |
| 2023-08-17 00:12 | 2023-08-14 | Torres Kathryn A. | Officer - SVP-Payer Contracting & Align. | SELL | $269.12 | 5,204 | $1,400,516 | 19,760 | -20.8% |
| 2023-08-16 00:20 | 2023-08-11 | Cohen Jeffrey E. | Officer - SVP-Government Relations | SELL | $270.00 | 1,500 | $405,000 | 4,414 | -25.4% |
| 2023-08-07 23:39 | 2023-08-03 | Whalen Kathleen M | Officer - SVP & Chief Ethics Officer | SELL | $270.00 | 2,916 | $787,320 | 10,250 | -22.1% |
| 2023-05-03 00:30 | 2023-04-28 | Cuffe Michael S. | Officer - EVP and Chief Clinical Officer | SELL | $284.44 | 12,556 | $3,571,396 | 28,783 | -30.4% |
| 2023-05-03 00:27 | 2023-04-28 | Akdamar Erol R | Officer - Group President | SELL | $285.00 | 3,500 | $997,500 | 42,484 | -7.6% |
| 2023-04-26 23:55 | 2023-04-24 | Torres Kathryn A. | Officer - SVP-Payer Contracting & Align. | SELL | $288.38 | 4,473 | $1,289,913 | 22,243 | -16.7% |
| 2023-04-15 00:51 | 2023-04-14 | Paslick P. Martin | Officer - SVP and CIO | OPT+S | $275.00 | 2,687 | $738,925 | 24,643 | 0.0% |
| 2023-04-13 01:23 | 2023-04-10 | Paslick P. Martin | Officer - SVP and CIO | SELL | $270.00 | 2,539 | $685,530 | 24,643 | -9.3% |
| 2023-04-07 01:26 | 2023-04-04 | Paslick P. Martin | Officer - SVP and CIO | OPT+S | $265.00 | 3,034 | $804,010 | 24,643 | 0.0% |
| 2023-02-23 04:10 | 2023-02-17 | Whalen Kathleen M | Officer - SVP & Chief Ethics Officer | SELL | $263.61 | 1,734 | $457,097 | 9,962 | -14.8% |
| 2023-02-10 02:15 | 2023-02-07 | Berres Jennifer | Officer - SVP & Chief Human Res. Officer | SELL | $255.23 | 4,000 | $1,020,912 | 7,392 | -35.1% |
| 2023-02-08 02:41 | 2023-02-03 | Reiner Deborah M | Officer - SVP - Mktg. & Communications | SELL | $257.61 | 7,941 | $2,045,699 | 0 | -100.0% |
| 2023-02-07 02:05 | 2023-02-02 | Akdamar Erol R | Officer - Group President | OPT+S | $258.63 | 3,000 | $775,891 | 34,726 | 0.0% |
| 2023-02-04 02:22 | 2023-02-03 | RUTHERFORD BILL B | Officer - CFO and EVP | OPT+S | $258.19 | 30,000 | $7,745,568 | 81,632 | 0.0% |
| 2023-02-02 04:08 | 2023-02-01 | Wyatt Christopher F. | Officer - SVP & Controller | OPT+S | $253.30 | 4,900 | $1,241,170 | 32,392 | 0.0% |
| 2023-02-02 04:03 | 2023-02-01 | Paslick P. Martin | Officer - SVP and CIO | SELL | $256.95 | 1,000 | $256,949 | 3,000 | -25.0% |
| 2023-02-02 04:02 | 2023-01-30 | McManus Timothy M | Officer - Group President | SELL | $254.06 | 7,900 | $2,007,067 | 13,987 | -36.1% |
How to Interpret $HCA Trades
Not every insider transaction in HCA Healthcare, Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $HCA shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for HCA
Insider activity data for HCA Healthcare, Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $HCA, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.